Petco EBITDA Jumps as Margins Expand

Petco Health and Wellness Company (NASDAQ:WOOF) reported Q2 2025 results reflecting a strategic pivot towards profitability, with adjusted EBITDA reaching $114 million and full-year guidance raised to a midpoint of $390 million, up 16% year-over-year. Despite a 2.3% net sales decline attributed to strategic store closures and exiting unprofitable channels, gross margin expanded over 120 basis points to 39.3% due to pricing discipline and operational improvements. This transformation also yielded strong free cash flow exceeding $50 million and a 9.5% reduction in inventory, signaling enhanced long-term earnings quality and reduced operating risk, although positive comparable sales are not anticipated until fiscal 2026.

Analysis

Petco's Q2 2025 results demonstrate a successful strategic pivot from top-line growth to profitability, a key element of its ongoing transformation. While net sales declined 2.3% year-over-year due to the deliberate closure of 35 net stores and an exit from unprofitable revenue streams, this was more than offset by significant margin improvement. Gross margin expanded by over 120 basis points to 39.3%, driven by a revised promotional strategy and pricing discipline. This focus on operational efficiency is further evidenced by free cash flow exceeding $50 million and a 9.5% reduction in inventory, which has fortified the balance sheet, now holding $190 million in cash and $684 million in total liquidity. Consequently, management raised its full-year fiscal 2025 adjusted EBITDA guidance to a midpoint of $390 million, representing a 16% year-over-year increase. Despite these strong profitability and cash flow metrics, the company does not anticipate a return to positive comparable sales until 2026, as the benefits of new merchandising and loyalty programs are expected to materialize over the longer term.

Key Decisions for Investors

• Investors should view Petco as a turnaround story, weighing the significant gross margin expansion and improved free cash flow against the near-term strategic decline in net sales.
• Given that positive comparable sales are not expected until 2026, the investment thesis requires patience and a focus on long-term earnings quality rather than immediate top-line growth.
• Key metrics to monitor for continued execution are gross margin trends, inventory discipline, and free cash flow generation, as these are the primary drivers of the current strategy's success.
• Consider the potential impact of intensifying tariffs toward year-end, which management has flagged as a headwind, though the company's strong liquidity provides a substantial buffer.